Treating schizophrenia at the time of menopause

被引：26

作者：

Seeman, Mary V. ^{[1
]}

机构：

[1] Univ Toronto, Dept Psychiat, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada

来源：

MATURITAS | 2012年 / 72卷 / 02期

关键词：

Schizophrenia; Menopause; Hormone replacement therapy; Antipsychotics; Estrogen; POSTMENOPAUSAL WOMEN; BIPOLAR DISORDER; DOUBLE-BLIND; ESTROGEN; PSYCHOSIS; THERAPY; GENDER; HEALTH; PHARMACOKINETICS; VARIABILITY;

D O I：

10.1016/j.maturitas.2012.03.008

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

The purpose of this review is to optimize treatment for women with schizophrenia during the menopause. Recommendations are based on a relatively sparse literature derived from searching PubMed, PsychINFO, SOCINDEX with appropriate search terms for all years subsequent to 2000. Attention needs to be paid to menopausal symptoms in women with schizophrenia and to the possibility that psychotic symptoms may worsen at this time and that general health may deteriorate. Antipsychotic treatment may need to be modified and cardiac and metabolic health indices closely monitored. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：117 / 120

页数：4

共 54 条

[1] What clinicians should know about the QT interval [J].

Al-Khatib, SM ;

LaPointe, NMA ;

Kramer, JM ;

Califf, RM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16) :2120-2127

[2] Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats [J].

Arad, Michal ;

Weiner, Ina .

PSYCHONEUROENDOCRINOLOGY, 2012, 37 (02) :200-212

[3] Contrasting Effects of Increased and Decreased Dopamine Transmission on Latent Inhibition in Ovariectomized Rats and Their Modulation by 17β-Estradiol: An Animal Model of Menopausal Psychosis? [J].

Arad, Michal ;

Weiner, Ina .

NEUROPSYCHOPHARMACOLOGY, 2010, 35 (07) :1570-1582

[4] PROLONGED ADMINISTRATION OF CHLORPROMAZINE (THORAZINE) HYDROCHLORIDE - CLINICAL AND LABORATORY SURVEY OF 50 PATIENTS [J].

AYD, FJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 169 (12) :1296-1301

[5] Neuroprotective actions of estradiol revisited [J].

Azcoitia, Inigo ;

Arevalo, Maria-Angeles ;

De Nicola, Alejandro F. ;

Garcia-Segura, Luis M. .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2011, 22 (12) :467-473

[6] Invited Commentary: Hormone Therapy Risks and Benefits-The Women's Health Initiative Findings and the Postmenopausal Estrogen Timing Hypothesis [J].

Banks, Emily ;

Canfell, Karen .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (01) :24-28

[7]

Barcelo M, 2007, PSIQ BIOL, V14, P187

[8] Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study [J].

Bergemann, N ;

Mundt, C ;

Parzer, P ;

Pakrasi, M ;

Eckstein-Mannsperger, U ;

Haisch, S ;

Salbach, B ;

Klinga, K ;

Runnebaum, B ;

Resch, F .

SCHIZOPHRENIA RESEARCH, 2005, 74 (2-3) :125-134

[9]

Bergemann N, 2002, Arch Womens Ment Health, V5, P119, DOI 10.1007/s00737-002-0004-2

[10] Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia [J].

Bergemann, Niels ;

Parzer, Peter ;

Runnebaum, Benno ;

Resch, Franz ;

Mundt, Christoph .

PSYCHOLOGICAL MEDICINE, 2007, 37 (10) :1427-1436

← 1 2 3 4 5 6 →